Kinetic analysis of multistep USP7 mechanism shows critical role for target protein in activity

USP7 is a highly abundant deubiquitinating enzyme (DUB), involved in cellular processes including DNA damage response and apoptosis. USP7 has an unusual catalytic mechanism, where the low intrinsic activity of the catalytic domain (CD) increases when the C-terminal Ubl domains (Ubl45) fold onto the CD, allowing binding of the activating C-terminal tail near the catalytic site. Here we delineate how the target protein promotes the activation of USP7. Using NMR analysis and biochemistry we describe the order of activation steps, showing that ubiquitin binding is an instrumental step in USP7 activation. Using chemically synthesised p53-peptides we also demonstrate how the correct ubiquitinated substrate increases catalytic activity. We then used transient reaction kinetic modelling to define how the USP7 multistep mechanism is driven by target recognition. Our data show how this pleiotropic DUB can gain specificity for its cellular targets.Deubiquitinating enzymes (DUBs) are critical regulators of cellular processes by removing ubiquitin from specific targets. Here global kinetic modelling reveals the mechanism by which the low intrinsic activity of USP7 is substantially enhanced on a specific physiological target.

[1]  Huaying Zhao,et al.  The role of mass transport limitation and surface heterogeneity in the biophysical characterization of macromolecular binding processes by SPR biosensing. , 2010, Methods in molecular biology.

[2]  H. Ovaa,et al.  A Native Chemical Ligation Handle that Enables the Synthesis of Advanced Activity-Based Probes: Diubiquitin as a Case Study , 2014, Chembiochem : a European journal of chemical biology.

[3]  D. Lim,et al.  The tumour suppressor RASSF1A promotes MDM2 self‐ubiquitination by disrupting the MDM2–DAXX–HAUSP complex , 2008, The EMBO journal.

[4]  Flore Kruiswijk,et al.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill , 2015, Nature Reviews Molecular Cell Biology.

[5]  Xin Zhou,et al.  Pan-cancer genome and transcriptome analyses of 1,699 pediatric leukemias and solid tumors , 2018, Nature.

[6]  V. Saridakis,et al.  Crystal Structure of USP7 Ubiquitin-like Domains with an ICP0 Peptide Reveals a Novel Mechanism Used by Viral and Cellular Proteins to Target USP7 , 2015, PLoS pathogens.

[7]  C. Yu,et al.  1H, 15N and 13C assignments of the calcium bound S100P , 2012, Biomolecular NMR Assignments.

[8]  Wayne Boucher,et al.  The CCPN data model for NMR spectroscopy: Development of a software pipeline , 2005, Proteins.

[9]  M. Rapé,et al.  Ubiquitylation at the crossroads of development and disease , 2017, Nature Reviews Molecular Cell Biology.

[10]  I. Wertz,et al.  DUBs, the regulation of cell identity and disease. , 2015, The Biochemical journal.

[11]  P. Di Lello,et al.  1H, 13C and 15N backbone resonance assignment for the 40.5 kDa catalytic domain of Ubiquitin Specific Protease 7 (USP7) , 2016, Biomolecular NMR assignments.

[12]  H. Ovaa,et al.  Catching a DUB in the act: novel ubiquitin-based active site directed probes , 2014, Current Opinion in Chemical Biology.

[13]  Gerbrand J. van der Heden van Noort,et al.  Non-hydrolyzable Diubiquitin Probes Reveal Linkage-Specific Reactivity of Deubiquitylating Enzymes Mediated by S2 Pockets , 2016, Cell chemical biology.

[14]  T. Bouwmeester,et al.  Biochemical characterization of USP7 reveals post‐translational modification sites and structural requirements for substrate processing and subcellular localization , 2007, The FEBS journal.

[15]  Elizabeth C. Townsend,et al.  Molecular basis of USP7 inhibition by selective small-molecule inhibitors , 2017, Nature.

[16]  Li Ma,et al.  The role of deubiquitinases in breast cancer , 2016, Cancer and Metastasis Reviews.

[17]  M. Rapé,et al.  The Ubiquitin Code , 2012, Annual review of biochemistry.

[18]  Wei Gu,et al.  p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.

[19]  A. Ciechanover,et al.  Degradation of ubiquitin: The fate of the cellular reaper , 2010, Cell cycle.

[20]  Muyang Li,et al.  Crystal Structure of a UBP-Family Deubiquitinating Enzyme in Isolation and in Complex with Ubiquitin Aldehyde , 2002, Cell.

[21]  W. Gu,et al.  Modulation of the p53/MDM2 interplay by HAUSP inhibitors. , 2017, Journal of molecular cell biology.

[22]  A. Scholten,et al.  On Terminal Alkynes That Can React with Active-Site Cysteine Nucleophiles in Proteases , 2013, Journal of the American Chemical Society.

[23]  Ping Wang,et al.  Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation , 2015, Nature Communications.

[24]  Ivan Dikic,et al.  Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. , 2012, Annual review of biochemistry.

[25]  D. Rigden,et al.  Deubiquitylases from genes to organism. , 2013, Physiological reviews.

[26]  T. Sixma,et al.  Layers of DUB regulation. , 2015, Trends in biochemical sciences.

[27]  J. Coulson,et al.  Cellular functions of the DUBs , 2012, Journal of Cell Science.

[28]  J. Qin,et al.  Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization , 2002, Nature.

[29]  D. Sterner,et al.  USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms. , 2017, Cell chemical biology.

[30]  T. Sixma,et al.  Regulation of USP7: A High Incidence of E3 Complexes. , 2017, Journal of molecular biology.

[31]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[32]  K. Anderson,et al.  Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7. , 2017, Cell chemical biology.

[33]  J. Rosenfeld,et al.  USP7 Acts as a Molecular Rheostat to Promote WASH-Dependent Endosomal Protein Recycling and Is Mutated in a Human Neurodevelopmental Disorder. , 2015, Molecular cell.

[34]  Victoria L. Murray,et al.  Practical protocols for production of very high yields of recombinant proteins using Escherichia coli , 2009, Protein science : a publication of the Protein Society.

[35]  T. Sixma,et al.  Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase. , 2011, Molecular cell.

[36]  Heather L. Mulder,et al.  The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes , 2014, Nature Communications.

[37]  C. Arrowsmith,et al.  Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. , 2005, Molecular cell.

[38]  R. Boelens,et al.  Altered flexibility in the substrate-binding site of related native and engineered high-alkaline Bacillus subtilisins. , 1999, Journal of molecular biology.

[39]  B. Vogelstein,et al.  HAUSP is Required for p53 Destabilization , 2004, Cell cycle.

[40]  J. Ernst,et al.  Molecular Understanding of USP7 Substrate Recognition and C-Terminal Activation. , 2016, Structure.

[41]  T. Sixma,et al.  Chemical Synthesis of Ubiquitin, Ubiquitin-Based Probes, and Diubiquitin** , 2010, Angewandte Chemie.

[42]  Alexander Varshavsky,et al.  The ubiquitin system, an immense realm. , 2012, Annual review of biochemistry.

[43]  Jessica L. Ziehr,et al.  A new general method for simultaneous fitting of temperature and concentration dependence of reaction rates yields kinetic and thermodynamic parameters for HIV reverse transcriptase specificity , 2017, The Journal of Biological Chemistry.

[44]  R. Hay,et al.  Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation , 2000, Molecular and Cellular Biology.

[45]  P. Tummino,et al.  C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site. , 2010, Archives of biochemistry and biophysics.

[46]  Zachary B. Simpson,et al.  FitSpace explorer: an algorithm to evaluate multidimensional parameter space in fitting kinetic data. , 2009, Analytical biochemistry.

[47]  R. Everett,et al.  A novel ubiquitin‐specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein , 1997, The EMBO journal.

[48]  D. Komander,et al.  Mechanisms of Deubiquitinase Specificity and Regulation. , 2017, Annual review of biochemistry.

[49]  Florian Gnad,et al.  USP7 small-molecule inhibitors interfere with ubiquitin binding , 2017, Nature.

[50]  F. Studier,et al.  Protein production by auto-induction in high density shaking cultures. , 2005, Protein expression and purification.

[51]  M. Rapé,et al.  The increasing complexity of the ubiquitin code , 2016, Nature Cell Biology.

[52]  H. Ovaa,et al.  Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity. , 2013, Immunity.

[53]  Marco Y. Hein,et al.  A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances , 2015, Cell.

[54]  H. Ploegh,et al.  Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. , 2002, Chemistry & biology.

[55]  Yuan-Tsong Chen,et al.  A marker for Stevens–Johnson syndrome , 2004 .

[56]  T. Sixma,et al.  Enabling high-throughput ligation-independent cloning and protein expression for the family of ubiquitin specific proteases. , 2011, Journal of structural biology.

[57]  Shili Duan,et al.  Molecular recognition of p53 and MDM2 by USP7/HAUSP , 2006, Nature Structural &Molecular Biology.

[58]  A. Bax,et al.  Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks , 2013, Journal of Biomolecular NMR.

[59]  Yigong Shi,et al.  Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53–MDM2 Pathway , 2006, PLoS biology.

[60]  René Bernards,et al.  TSPYL5 suppresses p53 levels and function by physical interaction with USP7 , 2011, Nature Cell Biology.

[61]  D. Sterner,et al.  Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3 + T-regulatory Cell Function and Promotes Antitumor Immunity , 2016, EBioMedicine.

[62]  Kenneth A. Johnson,et al.  1 Transient-State Kinetic Analysis of Enzyme Reaction Pathways , 1992 .

[63]  Carlo Rago,et al.  Tumour suppression: Disruption of HAUSP gene stabilizes p53 , 2004, Nature.

[64]  H. Ovaa,et al.  A General Chemical Ligation Approach Towards Isopeptide-Linked Ubiquitin and Ubiquitin-Like Assay Reagents , 2011, Chembiochem : a European journal of chemical biology.

[65]  M. Knörnschild,et al.  Corrigendum: Bats host major mammalian paramyxoviruses , 2014, Nature Communications.

[66]  T. Sixma,et al.  Structure of USP7 catalytic domain and three Ubl-domains reveals a connector α-helix with regulatory role. , 2016, Journal of structural biology.